News
PepGen to focus on development of DM1 programme following 10 mg/kg PGN-EDO51 update: Boston Friday, May 30, 2025, 14:00 Hrs [IST] PepGen Inc, a clinical-stage biotechnology compan ...
Eton Pharmaceuticals’ NDA for Khindivi receives US FDA nod for oral solution formulation: Deer Park, Illinois Friday, May 30, 2025, 13:00 Hrs [IST] Eton Pharmaceuticals, Inc, an ...
CPHI & PMEC China will be returning to the Shanghai New International Expo Center from June 24-26 amid a marked surge in international interest, with industry momentum rebounding following a string of ...
Innovent Biologics doses first participant in phase 3 clinical study of picankibart: San Francisco Friday, May 30, 2025, 12:00 Hrs [IST] Innovent Biologics, Inc, a world-class bio ...
The NIHR Research Programme for Social Care (RPSC) launched in July 2023. RPSC replaced NIHR’s Research for Social Care funding call to become a funding programme. The 14 newly-funded projects include ...
adopted a new resolution highlighting the global health financing emergency; endorsed first-ever resolutions on lung and kidney health, highlighting the upcoming UN General Assembly focus on ...
Daiichi Sankyo & Merck voluntarily withdraws patritumab deruxtecan BLA to treat locally advanced or metastatic EGFR-mutated NSCLC from US FDA: Basking Ridge, New Jersey Friday, Ma ...
Telangana IDMA elects KV Rambabu of Pulse Pharma as president, Sekhar Rao of TherDose Pharma new secretary: Our Bureau, ...
Nandita Vijayasimha, Bengaluru Friday, May 30, 2025, 08:00 Hrs [IST] ...
Shardul Nautiyal, Mumbai Friday, May 30, 2025, 08:00 Hrs [IST] ...
Delhi High Court upholds Patent Office's decision on Zeria Pharma's patent application: Our Bureau, New Delhi Friday, May 30, 2025, 08:00 Hrs [IST] The Delhi High Court has upheld ...
Immutep’s efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results